ScholarIQanswers from OpenAlex

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

PaperCitations, authors & open-access status

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes have?

ScholarIQcitation count

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes has 2,527 citations in the OpenAlex counts ScholarIQ stores.

When was Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes published?

ScholarIQyear

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes has 2013 year in the ScholarIQ index.

What is the open-access status of Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes?

ScholarIQoa status

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes has bronze oa status in the ScholarIQ index.

What is the DOI of Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes?

ScholarIQdoi

The DOI for Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes is on the source record.

What is the PMID of Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes?

ScholarIQpmid

The PMID for Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes is on the source record.

What is the OpenAlex record for Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes?

ScholarIQopenalex

The OpenAlex for Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial